Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancers|July 14, 2023
Systemic Neoadjuvant and Adjuvant Therapies in the Management of Hepatocellular Carcinoma-A Narrative ReviewShadi Chamseddine, Michael LaPelusa, Ahmed Omar Kaseb
Liver Cancer|April 13, 2026
Impact of Age on Patient-Reported Outcomes with First-Line Camrelizumab plus Rivoceranib versus Sorafenib in Adults with Unresectable Hepatocellular Carcinoma: Post Hoc Analyses of the CARES-310 Open-Label, Randomized, Phase 3 TrialStephen Lam Chan, Ahmed Omar Kaseb, Laura Alexander, et al.
Cancer Immunology Research|July 11, 2019
Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular CarcinomaAhmed Omar Kaseb, Luis Vence, Jorge Blando, et al.
Oncotarget|September 23, 2016
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinomaAhmed Omar Kaseb, Manal Hassan, Sahin Lacin, et al.
World Journal of Hepatology|October 9, 2020
Clinical efficacy of direct-acting antiviral therapy for recurrent hepatitis C virus infection after liver transplantation in patients with hepatocellular carcinomaMohamed Saleh Ismail, Manal Hassan, Saira Aijaz Khaderi, et al.
JCO Precision Oncology|February 9, 2022
Cholangiocarcinoma With <i>FGFR</i> Genetic Aberrations: A Unique Clinical PhenotypeApurva Jain, Mitesh J Borad, Robin Kate Kelley, et al.
Journal of Hepatocellular Carcinoma|June 4, 2024
A Post-International Gastrointestinal Cancers' Conference (IGICC) Position StatementsSuayib Yalcin, Sahin Lacin, Ahmed Omar Kaseb, et al.
Oncology|July 19, 2023
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular CarcinomaShadi Chamseddine, Yehia I Mohamed, Sunyoung S Lee, et al.
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular CarcinomaShadi Chamseddine, Betul Gok Yavuz, Yehia I Mohamed, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 7, 2017
A Double-Blind, Randomized, Placebo-Controlled Trial of <i>Panax Ginseng</i> for Cancer-Related Fatigue in Patients With Advanced CancerSriram Yennurajalingam, Nizar M Tannir, Janet L Williams, et al.
Pageof 2